Innovation1 Biotech Inc. (IVBT)

OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Nov 3, 2025
-75.00%
Market Cap 4.49K
Revenue (ttm) n/a
Net Income (ttm) -6.21M
Shares Out 22.47M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 153
Average Volume 1,691
Open 0.0002
Previous Close 0.0002
Day's Range 0.0002 - 0.0002
52-Week Range 0.0002 - 0.0050
Beta 17.37
RSI 39.87
Earnings Date Apr 17, 2026

About Innovation1 Biotech

Innovation1 Biotech Inc. focuses on researching, developing, producing, and selling pharmaceutical products. The company offers natural supplements for the treatment of symptoms associated with the flu and long covid under the NutraFlu and Nutravid19 brands; and other supplement and medical nutrition products. It also develops NLC001 that is in Phase II clinical trial for the treatment of long covid and other viral indications. The company is based in New York, New York. [Read more]

Industry Shell Companies
Sector Financials
Founded 2014
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol IVBT
Full Company Profile

Financial Performance

News

There is no news available yet.